Walgreen Co. (WAG) recently unveiled research results of two retrospective cohort studies that were involved with the study of HIV and comorbid medication adherence at the company’s HIV-specialized pharmacies. The studies also focused on implications for HIV patients suffering from serious mental disorders.

The research data was disclosed at the Cell-Lancet conference, What Will it Take to Achieve an AIDS-Free World? in San Francisco. It was inferred from the results that patients using Walgreens HIV-specialized pharmacies showed high adherence to therapeutic treatments for HIV as well as associated comorbidities, than those using other Walgreens retail pharmacies.

The HIV-specialized pharmacies of Walgreens are highly recognized. More than 2,000 HIV-trained pharmacists provide education, counseling, testing and treatment at more than 700 locations.